Clinical Trials Directory

Trials / Terminated

TerminatedNCT00720330

Lidocaine and Ketamine Versus Standard Care on Acute and Chronic Pain

The Effect of Thoracolumbar Paravertebral Block or Intravenous Lidocaine and Ketamine Versus Standard Care on Acute and Chronic Pain After Inguinal Herniorrhaphy

Status
Terminated
Phase
N/A
Study type
Interventional
Enrollment
12 (actual)
Sponsor
The Cleveland Clinic · Academic / Other
Sex
Male
Age
18 Years – 75 Years
Healthy volunteers
Not accepted

Summary

The investigators are conducting this study to find out if intravenous (injected through the vein) infusion of lidocaine and ketamine administered with general anesthesia is as effective as a paravertebral block in lessening pain after surgery and that both of these techniques are superior to general anesthesia alone in reducing pain immediately after surgery and in the long-term.

Detailed description

Participants will be randomized into one of three study groups; Group 1 - Paravertebral Group - ropivacaine is injected near the spine before surgery. Midazolam and fentanyl are administered intravenously for sedation. Group 2 - Lidocaine/Ketamine - General anesthesia with lidocaine and ketamine administered intravenously throughout your surgery and for 60 minutes after surgery. Group 3 - General Anesthesia Alone. General anesthesia with placebo administered intravenously throughout surgery and for 60 minutes after surgery. All participants will rate their pain on a scale from 0 to 10 after surgery and on days 1 and 2 after surgery. Participants are called 3 and 6 months after surgery for pain and quality of life assessments

Conditions

Interventions

TypeNameDescription
DRUGropivacaine10 ml 0.5% ropivacaine plus epinephrine will be injected at T11 and L1 as described above (20 ml total) using intravenous midazolam (1-2 mg) and fentanyl (0.5-1 mcg/kg) for sedation
DRUGLidocaine/KetaminePatients will receive a general anesthetic consisting of intravenous induction with lidocaine (1.5 mg/kg), propofol (1.5-2.5 mg/kg), ketamine (0.25 mg/kg), fentanyl (1 mcg/kg), and midazolam (1-2 mg).
OTHERplaceboplacebo

Timeline

Start date
2008-07-01
Primary completion
2010-02-01
Completion
2010-02-01
First posted
2008-07-22
Last updated
2019-03-12
Results posted
2017-05-19

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00720330. Inclusion in this directory is not an endorsement.

Lidocaine and Ketamine Versus Standard Care on Acute and Chronic Pain (NCT00720330) · Clinical Trials Directory